Literature DB >> 16844446

Neuroendocrine differentiation in prostate cancer.

Amir H Shariff1, M Hammad Ather.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16844446     DOI： 10.1016/j.urology.2006.02.002

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  13 in total

Review 1.  Molecular staging of prostate cancer in the year 2007.

Authors:  Thorsten Schlomm; Andreas Erbersdobler; Martina Mirlacher; Guido Sauter
Journal:  World J Urol       Date:  2007-03-02       Impact factor: 4.226

2.  Dual blockade of PKA and NF-κB inhibits H2 relaxin-mediated castrate-resistant growth of prostate cancer sublines and induces apoptosis.

Authors:  Ruth L Vinall; Christopher M Mahaffey; Ryan R Davis; Zunping Luo; Regina Gandour-Edwards; Paramita M Ghosh; Clifford G Tepper; Ralph W de Vere White
Journal:  Horm Cancer       Date:  2011-08       Impact factor: 3.869

3.  Pigment epithelium-derived factor and interleukin-6 control prostate neuroendocrine differentiation via feed-forward mechanism.

Authors:  Norm D Smith; Frank Thilo Schulze-Hoepfner; Dorina Veliceasa; Stephanie Filleur; Sarah Shareef; Lijun Huang; Xue-Mei Huang; Olga V Volpert
Journal:  J Urol       Date:  2008-04-23       Impact factor: 7.450

Review 4.  Neuroendocrine Tumors of the Prostate: Emerging Insights from Molecular Data and Updates to the 2016 World Health Organization Classification.

Authors:  David S Priemer; Rodolfo Montironi; Lisha Wang; Sean R Williamson; Antonio Lopez-Beltran; Liang Cheng
Journal:  Endocr Pathol       Date:  2016-06       Impact factor: 3.943

Review 5.  Small cell carcinoma of the prostate.

Authors:  Rosa Nadal; Michael Schweizer; Oleksandr N Kryvenko; Jonathan I Epstein; Mario A Eisenberger
Journal:  Nat Rev Urol       Date:  2014-02-18       Impact factor: 14.432

Review 6.  Molecular aspects of prostate cancer with neuroendocrine differentiation.

Authors:  Qi Li; Connie S Zhang; Yifen Zhang
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

7.  Proposed morphologic classification of prostate cancer with neuroendocrine differentiation.

Authors:  Jonathan I Epstein; Mahul B Amin; Himisha Beltran; Tamara L Lotan; Juan-Miguel Mosquera; Victor E Reuter; Brian D Robinson; Patricia Troncoso; Mark A Rubin
Journal:  Am J Surg Pathol       Date:  2014-06       Impact factor: 6.394

8.  Cushing's syndrome due to ectopic ACTH production by (neuroendocrine) prostate carcinoma.

Authors:  R A Alwani; S J C M M Neggers; M van der Klift; M G A Baggen; G J L H van Leenders; M O van Aken; A J van der Lely; W W de Herder; R A Feelders
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

9.  Protein kinase A-mediated phosphorylation of RhoA on serine 188 triggers the rapid induction of a neuroendocrine-like phenotype in prostate cancer epithelial cells.

Authors:  Sarah E Jones; Timothy M Palmer
Journal:  Cell Signal       Date:  2012-03-31       Impact factor: 4.315

10.  The genetics of neuroendocrine prostate cancers: a review of current and emerging candidates.

Authors:  M Hammad Ather; Tahmeena Siddiqui
Journal:  Appl Clin Genet       Date:  2012-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.